Status:
COMPLETED
Quantification of Liver Iron Overload and Steatosis Using Magnetic Resonance Imaging
Lead Sponsor:
Rennes University Hospital
Collaborating Sponsors:
Ministry of Health, France
Conditions:
Iron Overload
Metabolic Syndrome X
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Iron excess is increasingly regarded as an important cofactor in the morbidity attributed to many disorders. Assessment of body iron stores by measurement of serum ferritin concentrations has poor spe...
Detailed Description
Iron excess is increasingly regarded as an important cofactor in the morbidity attributed to many disorders. Assessment of body iron stores by measurement of serum ferritin concentrations has poor spe...
Eligibility Criteria
Inclusion
- Adults over 18,
- Planned liver biopsy (or liver biopsy within 2 months before inclusion) for one of these indications: suspicion of liver iron overload, metabolic syndrome, hepatitis B or C, alcohol abuse. No change in diet, transfusions or iron depletion must have occur between the liver biopsy and the MRI.
- Having given a written informed consent.
Exclusion
- Non cooperating patient,
- Patient with dyspnea,
- Patient with contra-indication to MR imaging (pace-maker, heart valve,...).
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2013
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT00401336
Start Date
November 1 2006
End Date
March 1 2013
Last Update
May 24 2023
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Angers
Angers, France, 49033
2
Hôpital Beaujon
Clichy, France, 92118
3
Hôpital Huriez
Lille, France, 59037
4
Hôpital Edouard Herriot
Lyon, France, 69003